Acute lymphoblastic leukemia in patients with Down syndrome with a previous history of acute myeloid leukemia.

about

Acute lymphoblastic leukemia in patients with Down syndrome with a previous history of acute myeloid leukemia.

Item

http://www.wikidata.org/entity/Q50220583

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Acute lymphoblastic leukemia i ...... ory of acute myeloid leukemia.

@en

Acute lymphoblastic leukemia i ...... ory of acute myeloid leukemia.

@nl

type

Item

label

Acute lymphoblastic leukemia i ...... ory of acute myeloid leukemia.

@en

Acute lymphoblastic leukemia i ...... ory of acute myeloid leukemia.

@nl

prefLabel

Acute lymphoblastic leukemia i ...... ory of acute myeloid leukemia.

@en

Acute lymphoblastic leukemia i ...... ory of acute myeloid leukemia.

@nl

P1476

Acute lymphoblastic leukemia i ...... ory of acute myeloid leukemia.

@en

P2093

Akifumi Endo

http://www.w3.org/2001/XMLSchema#string

Daisuke Tomizawa

http://www.w3.org/2001/XMLSchema#string

Hirotoshi Sakaguchi

http://www.w3.org/2001/XMLSchema#string

Kimikazu Matsumoto

http://www.w3.org/2001/XMLSchema#string

Makoto Kaneda

http://www.w3.org/2001/XMLSchema#string

Michiko Kajiwara

http://www.w3.org/2001/XMLSchema#string

Takashi Taga

http://www.w3.org/2001/XMLSchema#string

P2860

Risks of leukaemia and solid tumours in individuals with Down's syndrome.

Acute leukemia as a secondary malignancy in children and adolescents: current findings and issues.

Assessment of corticosteroid-induced osteonecrosis in children undergoing chemotherapy for acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group.

Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group.

Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia.

Normal karyotype is a poor prognostic factor in myeloid leukemia of Down syndrome: a retrospective, international study.

Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group.

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.

Prospective study of a pirarubicin, intermediate-dose cytarabine, and etoposide regimen in children with Down syndrome and acute myeloid leukemia: the Japanese Childhood AML Cooperative Study Group.

Clinical characteristics and outcome of refractory/relapsed myeloid leukemia in children with Down syndrome.

P31

scholarly article

P356

10.1002/PBC.26411

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28012245

http://www.w3.org/2001/XMLSchema#string